PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01).

被引:1
|
作者
Cui, Shu-zhong
Liang, Han
Li, Yong
Zhou, Yanbing
Tao, Kaixiong
Zhou, Zhiwei
Li, Guoxin
Li, Peiyu
Zhou, Baojun
Yao, Hongliang
Peng, Zheng
Xiong, Bin
Pang, Minghui
Cai, Shirong
Wan, Jin
Liang, Bin
Lei, Ziying
Wang, Jiping
机构
[1] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
[3] Hebei Med Univ, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China
[4] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[6] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[7] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China
[8] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[9] Hebei Med Univ, Affiliated Hosp 2, Shijiazhuang, Hebei, Peoples R China
[10] Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China
[11] Wuhan Univ, Zhongnan Hosp, Wuhan, Peoples R China
[12] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China
[13] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[14] Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China
[15] Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Peoples R China
[16] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[17] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4538
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
    Yang, Xiao-Jun
    Huang, Chao-Qun
    Suo, Tao
    Mei, Lie-Jun
    Yang, Guo-Liang
    Cheng, Fu-Lin
    Zhou, Yun-Feng
    Xiong, Bin
    Yonemura, Yutaka
    Li, Yan
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (06) : 1575 - 1581
  • [32] Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial
    Maneesh Kumarsing Beeharry
    Zhen-Tian Ni
    Zhong Yin Yang
    Ya Nan Zheng
    Run Hua Feng
    Wen-Tao Liu
    Chao Yan
    Xue Xin Yao
    Chen Li
    Min Yan
    Zheng-Gang Zhu
    BMC Cancer, 20
  • [33] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
    Xiao-Jun Yang
    Chao-Qun Huang
    Tao Suo
    Lie-Jun Mei
    Guo-Liang Yang
    Fu-Lin Cheng
    Yun-Feng Zhou
    Bin Xiong
    Yutaka Yonemura
    Yan Li
    Annals of Surgical Oncology, 2011, 18 : 1575 - 1581
  • [34] CLASS-05 trial: A randomized controlled phase III trial of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy vesus systemic chemotherapy alone for patients with limited peritoneal carcinomatosis of gastric cancer
    Liu, H.
    Li, G.
    Yu, J.
    Su, X.
    Sun, Y.
    Hu, J.
    Huang, L.
    Zhou, Z.
    Li, Y.
    Yu, J.
    Wei, H.
    Peng, J.
    Wu, Z.
    Chen, H.
    Cui, S.
    Hu, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [35] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Trial Results of a Phase 2, Randomized, Clinical Trial
    Peng Wang
    Zhi-xiang Zhou
    Annals of Surgical Oncology, 2017, 24 : 623 - 623
  • [36] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Trial Results of a Phase 2, Randomized, Clinical Trial
    Wang, Peng
    Zhou, Zhi-xiang
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S623 - S623
  • [37] Comparison of totally laparoscopic and laparoscopic-assisted approach in gastrectomy with D2 lymphadenectomy for advanced gastric cancer after neoadjuvant chemotherapy: a retrospective comparative study
    Chen, Zhenyu
    Chen, Guangyu
    Li, Yan
    Kou, Sha
    Wang, Tao
    Zhang, Lin
    Cao, Yongkuan
    Liu, Liye
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2024, 106 (04) : 218 - 224
  • [38] Perioperative chemotherapy vs. adjuvant chemotherapy for potentially resectable gastric cancer: A randomized and multicenter phase III study in locally advanced gastric cancer with D2 dissection.
    Zhao, Qun
    Li, Yong
    Lian, Changhong
    Li, Baozhong
    Li, Wenxin
    Huo, Zhibin
    Wang, Zunyi
    Wang, Yimin
    Tian, Yuan
    Xie, Shuzhe
    Li, Shoumiao
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Correction to: Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study
    Maneesh Kumarsing Beeharry
    Zheng-Lun Zhu
    Wen-Tao Liu
    Xue-Xin Yao
    Min Yan
    Zheng-Gang Zhu
    BMC Cancer, 19
  • [40] Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)
    Ji, J.
    Shen, L.
    Li, Z.
    Zhang, X.
    Liang, H.
    Xue, Y.
    Wang, Y.
    Zhou, Z.
    Yu, J.
    Chen, L.
    Du, Y.
    Li, G.
    Xiao, G.
    Wu, D.
    Zhou, Y.
    Dang, C.
    He, Y.
    Zhang, Z.
    Sun, Y.
    Li, Y.
    ANNALS OF ONCOLOGY, 2019, 30 : 877 - 877